Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
4
4 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- HRS-1893Phase 35 trials
Shandong Suncadia Medicine Co., Ltd. · Obstructive Hypertrophic Cardiomyopathy, Heart Failure With Preserved Ejection Fraction, Hypertrophic Cardiomyopathy
- BHB-1893Phase 32 trials
Braveheart Bio, Inc. · Cardiomyopathy, Hypertrophic Non-Obstructive, Cardiomyopathy, Hypertrophic Obstructive
- ATR 1072Phase 21 trial
Atrium Therapeutics · Cardiac Glycogenosis, Cardiomyopathy, Hypertrophic
- EDG-7500Phase 21 trial
Edgewise Therapeutics, Inc. · Hypertrophic Cardiomyopathy
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.